tiprankstipranks
Trending News
More News >
Advertisement

VFVA - ETF AI Analysis

Compare

Top Page

VFVA

Vanguard U.S. Value Factor ETF (VFVA)

Rating:69Neutral
Price Target:
VFVA, the Vanguard U.S. Value Factor ETF, earns a solid overall rating driven by strong, cash-generative value names like Verizon, EOG Resources, Bristol-Myers Squibb, and FedEx, which combine attractive valuations with healthy financial performance and generally positive outlooks. The fund is somewhat held back by weaker spots such as CVS Health and Altria, where leverage, technical pressure, and business challenges add risk, and investors should also note the concentration in traditional value sectors like telecom, healthcare, and consumer staples, which can lag in high-growth market environments.
Positive Factors
Low Expense Ratio
The fund charges relatively low fees, which helps investors keep more of their returns over time.
Broad Sector Diversification
Holdings are spread across many sectors, including financials, health care, consumer, technology, and energy, which helps reduce the impact of weakness in any single industry.
Solid Recent Performance
The ETF has shown steady gains over the past month, three months, and year to date, indicating recent positive momentum.
Negative Factors
Heavy U.S. Concentration
Almost all of the fund’s assets are invested in U.S. companies, offering very limited international diversification.
Mixed Performance Among Top Holdings
Several of the largest positions, such as Comcast, Verizon, AT&T, and Cigna, have shown weak or negative performance this year, which can drag on overall returns.
Sector Tilts May Increase Risk
Large weights in financials and health care mean the fund could be more sensitive to downturns or regulatory changes in those areas.

VFVA vs. SPDR S&P 500 ETF (SPY)

VFVA Summary

Vanguard U.S. Value Factor ETF (VFVA) is a U.S.-focused fund that follows a value-investing theme, aiming to buy stocks that look cheap compared with their business fundamentals. It holds a wide mix of companies across many sectors, including well-known names like Comcast and Verizon, with a tilt toward financial and health care stocks. Someone might invest in VFVA to seek long-term growth from undervalued companies while staying diversified across the broader U.S. market. A key risk is that value stocks can stay out of favor for long periods, so the price can go up and down more than you expect.
How much will it cost me?The Vanguard U.S. Value Factor ETF (VFVA) has an expense ratio of 0.13%, meaning you’ll pay $1.30 per year for every $1,000 invested. This is lower than average because it is passively managed, focusing on a value-oriented strategy that keeps costs down while providing diversified exposure to undervalued stocks.
What would affect this ETF?The Vanguard U.S. Value Factor ETF (VFVA) could benefit from a strong U.S. economy, particularly if undervalued sectors like Financials, Health Care, and Consumer Cyclical experience growth. However, rising interest rates or economic slowdowns could negatively impact some of its top holdings, such as banks and consumer-focused companies, while regulatory changes in sectors like Health Care or Technology may also pose risks.

VFVA Top 10 Holdings

VFVA’s story is classic U.S. value: no single stock dominates, but a handful of old-school names are doing the heavy lifting. FedEx has been flying high lately, giving the fund a nice boost, while Verizon, AT&T, and Comcast add steady, telecom-style ballast with generally rising trends. On the defensive side, Bristol-Myers Squibb has been a quiet positive in health care, but CVS is losing steam and acting as a drag. Overall, the ETF leans into U.S. value across sectors, with no big-tech glamour and no overseas exposure.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Comcast1.01%$7.77M$109.99B-13.13%
74
Outperform
Bristol-Myers Squibb0.97%$7.48M$122.15B0.28%
78
Outperform
Verizon0.97%$7.43M$213.75B19.00%
81
Outperform
EOG Resources0.94%$7.22M$71.09B6.63%
78
Outperform
AT&T0.93%$7.17M$190.14B5.60%
71
Outperform
Salesforce0.89%$6.82M$179.18B-31.78%
80
Outperform
Cigna0.89%$6.81M$68.75B-16.13%
72
Outperform
CVS Health0.88%$6.75M$96.33B16.78%
64
Neutral
General Motors0.85%$6.51M$67.61B56.14%
73
Outperform
FedEx0.78%$5.96M$84.97B48.41%
79
Outperform

VFVA Technical Analysis

Technical Analysis Sentiment
Negative
Last Price
Price Trends
50DMA
139.19
Negative
100DMA
133.86
Positive
200DMA
127.48
Positive
Market Momentum
MACD
-0.64
Positive
RSI
36.20
Neutral
STOCH
32.29
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For VFVA, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 140.87, equal to the 50-day MA of 139.19, and equal to the 200-day MA of 127.48, indicating a neutral trend. The MACD of -0.64 indicates Positive momentum. The RSI at 36.20 is Neutral, neither overbought nor oversold. The STOCH value of 32.29 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for VFVA.

VFVA Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$762.70M0.13%
69
Neutral
$552.41M0.40%
75
Outperform
$484.37M0.28%
73
Outperform
$389.10M0.38%
71
Outperform
$302.91M0.60%
71
Outperform
$215.18M0.50%
69
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
VFVA
Vanguard U.S. Value Factor ETF
134.03
22.25
19.91%
LSVD
LSV Disciplined Value ETF
QVAL
Alpha Architect U.S. Quantitative Value ETF
AIVL
WisdomTree U.S. AI Enhanced Value Fund
BUSA
Brandes U.S. Value ETF
GVLU
Gotham 1000 Value ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement